Alvarez & Marsal’s Jay Moody, Managing Director, Global Transaction Advisory Group, spoke to Mergers & Acquisitions about his reaction to President Biden’s infrastructure bill.

In a recent Modern Healthcare article, “7 Due Diligence Issues to Avoid False Claims Act Lawsuits,” Mike Cole Managing Director and Healthcare Industry Leader of Alvarez & Marsal’s Global Transaction Advisory Group, discusses the importance of due diligence with private equity firms. 

In the fourth installment of A&M’s Your Next Deal Will Be Different series, we examine talent strategy and retention during the Great Resignation.

Gao Huan speaks to Bloomberg TV about China Singles’ Day

Chinese biotechs push healthcare IPOs past 2020 total in Q3'21

Joey Baruch Shares Smart Best Practices For Reviewing Code

The Democrats are planning to move full speed ahead to enact their signature Build Back Better Act, but the proposal that the House just passed could face significant hurdles crossing the finish line as it enters the Senate budget reconciliation process.

The Investment Association (“the IA”) has today written to FTSE All Share Remuneration Committee Chairs to summarise the outcome of its annual review of its Principles of Remuneration.

In this issue, A&M examines the benefits of a flexible cost structure for automotive companies as the selected topic for the November Industry Focus.

Alvarez & Marsal's (A&M’s) Compensation and Benefits Practice is pleased to share the results of its 2021/2022 Executive Change in Control Report.

How can automotive suppliers remain profitable in a highly volatile environment? The automotive industry is undergoing a transformation of unparalleled dimension in its history. Powertrain electrification, connectivity, shared mobility, and autonomous driving are challenging existing business models and the entire automotive value chain. 

It’s still advantageous for UK subsidiaries of US companies to make UK research and development (R&D) credit claims.

Many Med Tech companies are still experiencing challenges as we move into a post-pandemic world. The cost of distribution has increased substantially, working capital has exploded, service levels have deteriorated, and profitability has suffered. A&M’s Healthcare & Life Sciences team set out approaches to adapt to the new environment, while achieving up to 3-5 percentage points improvement of EBITDA.

In this workshop session, industry experts examined remuneration and governance best practices and discussed how to find the right balance across all stakeholders.